Mayo Clinic reports first EndoDrill GI lower-GI EUS biopsy case, BibbInstruments says

  • BibbInstruments flagged new clinical evidence already presented at ESGE Days 2026 by Mayo Clinic physicians on use of its EndoDrill GI device in the lower gastrointestinal tract.
  • The case showed a successful ultrasound-guided core biopsy of tissue adjacent to the rectum, yielding sufficient material from a single pass with no reported complications.
  • Pathology workup from the sample supported a diagnosis of high-grade urothelial cancer, highlighting potential utility in difficult-to-sample lesions.
  • The presenters described the procedure as the first reported use of EndoDrill GI for lower GI tissue sampling, extending the clinical footprint beyond prior experience in pancreatic lesions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BibbInstruments AB published the original content used to generate this news brief on May 21, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.